Cintas Corporation (CTAS) Guidance & Earnings Results

On 2026-09-23 Cintas Corporation raised guidance: "FY2027 revenue raised to $12.15-12.27B from $12.10-12.25B; adjusted diluted EPS raised to $5.45-5.54 from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason

CTASCintas CorporationFollow CTAS — free

Specialty Business Services · Industrials

—

Price chart with a free account

Market cap: 89.0B
P/E TTM: 44.2
Dividend yield: 0.8%
52-week: —
Next earnings: 16 Dec, in 53 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
23 Sep 26	Raised	FY2027 revenue raised to $12.15-12.27B from $12.10-12.25B; adjusted diluted EPS raised to $5.45-5.54 from $5.36-5.50 · full year
15 Jul 26	Raised	FY2027 revenue $12.10-12.25B (from FY2026 $11.26B); FY2027 adjusted diluted EPS $5.36-5.50 (from FY2026 $4.94); FY2027 interest expense net ~$105.0M; FY2027 effective tax rate 20.2%
25 Mar 26	Raised	Revenue $11.21B-$11.24B; adjusted EPS $4.86-$4.90 · full year
18 Dec 25	Raised	Revenue guidance raised by ~$0.1B; EPS guidance raised by ~$0.07 · full year
24 Sep 25	Raised	Revenue guidance raised by $90M at midpoint; EPS guidance raised by $0.02 at midpoint · full year

Cintas Corporation — questions

What guidance did Cintas Corporation give?: On 2026-09-23: "FY2027 revenue raised to $12.15-12.27B from $12.10-12.25B; adjusted diluted EPS raised to $5.45-5.54 from $5.36-5.50"
When does Cintas Corporation report earnings?: Cintas Corporation's next earnings report is expected on 2026-12-16.

Every figure on this page comes from Cintas Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.